Shared Decision Making in Melanoma Patients Receiving Adjuvant Therapy: Development of a Decision Aid Tool
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
This study aims to develop test and evaluate a Patient Decision Aid called The Decision Helper among melanoma patients eligible for adjuvant treatment. * Is the Decision Helper an acceptable tool for patients and clinicians and is it feasible in clinical practice? * Are there any differences in the levels of decisional regret in the patients who have not used the Decision Helper (pre-implementation) compared to the ones who have (post-implementation?
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 100
View:
• Danish speaking
• Diagnosed with stage 3 malignant melanoma
• Eligible for adjuvant immunotherapy
Locations
Other Locations
Denmark
Odense University Hospital
RECRUITING
Odense C
Contact Information
Primary
Lærke K Tolstrup, PhD
laerke.tolstrup@rsyd.dk
40295129
Time Frame
Start Date: 2022-03-01
Estimated Completion Date: 2024-12-30
Participants
Target number of participants: 150
Related Therapeutic Areas
Sponsors
Leads: Odense University Hospital
Collaborators: University of Copenhagen, Aalborg University Hospital, Aarhus University Hospital